- Metabolite
- HMDB0094690 (Tetramethylsilane)
- Biospecimen
- Feces
- Status
- Detected but not Quantified
- Data source
- Referenced
- Concentration
- Not Quantified
- Age
- Adult (>18 years old)
- Sex
- Both
- Condition
- irritable bowel syndrome
References
- Zeber-Lubecka N, Kulecka M, Ambrozkiewicz F, Paziewska A, Goryca K, Karczmarski J, Rubel T, Wojtowicz W, Mlynarz P, Marczak L, Tomecki R, Mikula M, Ostrowski J: Limited prolonged effects of rifaximin treatment on irritable bowel syndrome-related differences in the fecal microbiome and metabolome. Gut Microbes. 2016 Sep 2;7(5):397-413. doi: 10.1080/19490976.2016.1215805. Epub 2016 Jul 26. [PubMed:27662586 ]